NDC 83589-0157-08: Penetratin 1 g/g Powder, 100 g Bottle
This is a package of 100 g of Penetratin 1 g/g Powder from Nanjing Chengong Pharmaceutical Co., Ltd., first listed with the FDA Feb 2026 and currently FDA-listed.
NDC database record
One package, one record: these facts belong to NDC 83589-157-08 alone.
- Record
- FDA NDC Directory package listing · Bulk ingredient
- Code segments
- 83589 labeler · 157 product · 08 package
- Package marketed since
- Feb 25, 2026
- Listing certified through
- Dec 31, 2027
- Barcode (UPC-A, from the NDC)
- 3 8358915708 3
- FDA record last changed
- Aug 20, 2026
Identity & classification
Regulatory identifiers FDA, NLM and CMS codes for this package
Where does this data come from?
- FDA openFDA NDC Directory · synced Nov 19, 2026
- FDA label on DailyMed · label index refreshed Nov 21, 2026
- RxNorm (NLM RxNav) · catalog refreshed Nov 19, 2026
- Medi-Span GPI (licensed)
- First Databank (licensed) · refreshed Nov 19, 2026
Clinical
Penetratin 1 g/g Powder is a bulk ingredient, not a finished consumer product. It is supplied as a powder form for use by licensed manufacturers or compounders in creating finished medicines. Penetratin is a cell-penetrating peptide typically used in pharmaceutical formulations to help other active ingredients cross cell membranes more effectively. This substance appears in research and specialized compounded products where enhanced cellular uptake of therapeutic agents is desired.
Patient education
Supplement & herbal interactions
Where does this data come from?
- MedlinePlus (NLM) · refreshed Nov 19, 2026
- FDA label on DailyMed · label index refreshed Nov 21, 2026
Ask a licensed pharmacist directly — free, answered by our team.
Pricing
A drug doesn't have one price. Each row is a different public payment system, and none is what you'd pay at the counter — that depends on your insurance. The ⓘ on each row explains what it measures.
| Price system | Per g | Per package |
|---|---|---|
| Retail pharmacies payNADAC · weekly | Not in the retail survey — common for institutional, discontinued, or low-volume packs. | |
| Medicaid paysCMS SDUD · 12 mo | No recent Medicaid claims on file for this NDC — rare and low-volume NDCs are suppressed in the public data. | |
| Medicare drug plans payPart D · quarterly | No Part D plan price is available for this NDC in our data. | |
Where does this data come from?
- CMS NADAC weekly file
- CMS ASP pricing files · refreshed Nov 20, 2026
- CMS Medicaid State Drug Utilization Data · refreshed Nov 19, 2026
- CMS Part D plan pricing files · refreshed Oct 24, 2026
- VA National Acquisition Center price file
Packaging — all sizes for this product
| Package NDC | Description | Marketing start | Marketing end | Status |
|---|---|---|---|---|
| 83589-0157-01 83589-157-01 Main listing | 1 g in 1 VIAL | — | — | Active |
| 83589-0157-02 83589-157-02 | 1 g in 1 BOTTLE | — | — | Active |
| 83589-0157-03 83589-157-03 | 5 g in 1 VIAL | — | — | Active |
| 83589-0157-04 83589-157-04 | 5 g in 1 BOTTLE | — | — | Active |
| 83589-0157-05 83589-157-05 | 10 g in 1 BOTTLE | — | — | Active |
| 83589-0157-06 83589-157-06 | 50 g in 1 BOTTLE | — | — | Active |
| 83589-0157-07 83589-157-07 | 50 g in 1 BAG | — | — | Active |
| 83589-0157-08 You're viewing this | 100 g in 1 BOTTLE | — | — | Active |
| 83589-0157-09 83589-157-09 | 100 g in 1 BAG | — | — | Active |
| 83589-0157-10 83589-157-10 | 250 g in 1 BAG | — | — | Active |
| 83589-0157-11 83589-157-11 | 500 g in 1 BAG | — | — | Active |
Pack size FAQ
What quantity is in this package?
How does this package differ from NDC 83589-0157-01?
What NDC number is used to bill for this package of Penetratin 1 g/g Powder?
Therapeutic equivalents
| Product | Labeler | Pack | NADAC/unit | TE | Status | Price vs. this |
|---|---|---|---|---|---|---|
| Penetratin 1 g/gthis 83589-0157-08 | Nanjing | 100 g | — | — | FDA listed | — |
| Penetratin 1 g/g 73212-0105-01 | Qingdao | 1 g | — | — | FDA listed | — |
Where does this data come from?
- FDA openFDA NDC Directory · synced Nov 19, 2026
- FDA Orange Book · refreshed Nov 6, 2026
- CMS NADAC weekly file
Availability & generic status
We did not find an FDA-approved generic match for this exact strength, form and route.
Where does this data come from?
- FDA Orange Book · refreshed Nov 6, 2026
Inactive Ingredients / Excipients
Inactive ingredients, also called excipients, are components of the drug product other than the active ingredient. They may include fillers, dyes, coatings, preservatives, flavors, or other formulation ingredients.
Where does this data come from?
IACT rows and label-wide narrative are kept separate; availability and product-level specificity depend on the submitted label.- FDA label on DailyMed · label index refreshed Nov 21, 2026
- FDA openFDA NDC Directory · synced Nov 19, 2026
Inactive ingredient FAQ
Are inactive ingredients the same for every manufacturer?
Why might an inactive ingredient be missing?
Can inactive ingredients matter?
Manufacturer & labeler
More NDCs from Nanjing Chengong Pharmaceutical Co., Ltd. labeler code 83589
- GHRP-2 Acetate 1 g/g Powder NDC 83589-151-01
- GHRP-6 Acetate 1 g/g Powder NDC 83589-152-01
- ACE-031 Acetate 1 g/g Powder NDC 83589-153-01
- SNAP-8 1 g/g Powder NDC 83589-154-01
- MGF Acetate 1 g/g Powder NDC 83589-155-01
- Dulaglutide Sodium Salt 1 g/g Powder NDC 83589-156-01
- Macimorelin Acetate 1 g/g Powder NDC 83589-158-01
- Leuprolide Acetate 1 g/g Powder NDC 83589-159-01
- Gonadorelin HCl 1 g/g Powder NDC 83589-160-01
- Ecnoglutide 1 g/g Powder NDC 83589-161-01
- Mazdutide 1 g/g Powder NDC 83589-162-01
- ABP-7 Acetate 1 g/g Powder NDC 83589-163-01
Where does this data come from?
- FDA openFDA NDC Directory · synced Nov 19, 2026
- Drugs@FDA
Full FDA label FDA SPL
📄 FDA label ▾
No FDA label is on file for this product yet. Labels load from openFDA / DailyMed and refresh weekly.
About this NDC listing & data coverage
This is a bulk ingredient listing — not a retail prescription package
Penetratin 1 g/g POWDER is listed with FDA as a bulk ingredient (a drug substance supplied for further manufacturing or licensed pharmacy compounding). It is not a finished product a patient would receive at a retail pharmacy, so consumer-style information — a patient label, retail pricing, package photos — generally does not exist for this NDC. The listing identifies the substance and package for supply-chain and regulatory purposes.
What data is (and isn’t) available for this NDC — tap to expand
| NDC identity (package / product / labeler codes) | ✓ Available |
| Labeler | ✓ Available |
| Product & package description | ✓ Available |
| Marketing category & status | ✓ Available |
| Active ingredient / dosage form / route | ✓ Available |
| FDA label (SPL via DailyMed) | ✓ Available |
| Package photos | — Not published for this NDC No photo available yet for this listing. |
| Inactive ingredients (structured) | — Not published for this NDC The labeler did not submit a structured excipient list, or no SPL is available. |
| NADAC pharmacy acquisition price (CMS) | — Not published for this NDC CMS publishes NADAC only for NDCs reported in its retail-pharmacy survey. |
| Orange Book / therapeutic-equivalence data | — Not published for this NDC Applies only to products approved under an NDA/ANDA; many listings are out of scope. |
| HCPCS J-code billing crosswalk | — Not published for this NDC Most self-administered / retail products have no J-code — that is normal. |
| Medicaid utilization (CMS SDUD) | — Not published for this NDC CMS reports utilization only for NDCs with Medicaid claims above its privacy threshold. |